Difference between revisions of "I-123 Biomarker Committee"
Jump to navigation
Jump to search
Line 16: | Line 16: | ||
==Reference Materials== | ==Reference Materials== | ||
− | *[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf | QIBA SPECT I-123 Biomarker Committee Presentation]] ''John Seibyl, MD'' | + | *[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf | QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018)]] ''John Seibyl, MD'' |
Revision as of 20:49, 16 November 2018
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- Secretary: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD